サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1748326

ペットの狂犬病ワクチンの世界市場：市場レポート、競合分析、地域別機会 (2025年～2031年)

Global Pets Rabies Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

出版日
発行
QYResearch
ページ情報
英文 93 Pages
納期
2～3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.42円
ペットの狂犬病ワクチンの世界市場：市場レポート、競合分析、地域別機会 (2025年～2031年)
出版日: 2025年06月16日
発行: QYResearch
ページ情報: 英文 93 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、ペットの狂犬病ワクチン (Pets Rabies Vaccine) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 市場の事業概要

  • ペットの狂犬病ワクチン 製品範囲
  • ペットの狂犬病ワクチン タイプ別
    • 世界のペットの狂犬病ワクチン 販売：タイプ別 (2020 & 2024 & 2031)
    • Animal Cell Culture Vaccines
    • Human Cell Culture Vaccines
  • ペットの狂犬病ワクチン 用途別
    • 世界のペットの狂犬病ワクチン 売上 比較：用途別 (2020 & 2024 & 2031)
    • For Dogs
    • For Cats
    • For Other Pets
  • 世界のペットの狂犬病ワクチン 市場 推定および予測 (2020-2031)
    • 世界のペットの狂犬病ワクチン 市場規模 in 価格 成長率 (2020-2031)
    • Global Pets Rabies Vaccine Market Size in Volume Growth Rate (2020-2031)
    • Global Pets Rabies Vaccine Price Trends (2020-2031)
  • 前提条件と制限

第2章 市場規模と予測：地域別

  • 世界のペットの狂犬病ワクチン 市場規模：地域別: 2020 VS 2024 VS 2031
  • 世界のペットの狂犬病ワクチン 過去の市場分析：地域別 (2020-2025)
    • 世界のペットの狂犬病ワクチンの販売市場シェア 地域別 (2020-2025)
    • 世界のペットの狂犬病ワクチンの収益市場シェア 地域別 (2020-2025)
  • 世界のペットの狂犬病ワクチン 市場 推定および予測 地域別 (2026-2031)
    • 世界のペットの狂犬病ワクチン 売上予測・予想 地域別 (2026-2031)
    • 世界のペットの狂犬病ワクチンの収益予測：地域別 (2026-2031)
  • 主要地域と新興市場分析
    • 北米のペットの狂犬病ワクチン 市場規模および予測 (2020-2031)
    • 欧州のペットの狂犬病ワクチン 市場規模および予測 (2020-2031)
    • 中国のペットの狂犬病ワクチン 市場規模および予測 (2020-2031)
    • 日本のペットの狂犬病ワクチン 市場規模および予測 (2020-2031)

第3章 世界の市場規模：タイプ別

  • 世界のペットの狂犬病ワクチンの過去の市場概要：タイプ別 (2020-2025)
    • 世界のペットの狂犬病ワクチン 販売：タイプ別 (2020-2025)
    • 世界のペットの狂犬病ワクチン 収益：タイプ別 (2020-2025)
    • 世界のペットの狂犬病ワクチン 価格：タイプ別 (2020-2025)
  • 世界のペットの狂犬病ワクチンの市場 推定および予測：タイプ別 (2026-2031)
    • 世界のペットの狂犬病ワクチンの販売予測：タイプ別 (2026-2031)
    • 世界のペットの狂犬病ワクチンの収益予測：タイプ別 (2026-2031)
    • 世界のペットの狂犬病ワクチンの価格予測：タイプ別 (2026-2031)
  • 各種タイプ ペットの狂犬病ワクチン 代表的な企業

第4章 世界の市場規模：用途別

  • 世界のペットの狂犬病ワクチンの過去の市場概要：用途別 (2020-2025)
    • 世界のペットの狂犬病ワクチン 販売：用途別 (2020-2025)
    • 世界のペットの狂犬病ワクチン 収益：用途別 (2020-2025)
    • 世界のペットの狂犬病ワクチン 価格：用途別 (2020-2025)
  • 世界のペットの狂犬病ワクチン 市場 推定および予測：用途別 (2026-2031)
    • 世界のペットの狂犬病ワクチンの販売予測：用途別 (2026-2031)
    • 世界のペットの狂犬病ワクチンの収益予測：用途別 (2026-2031)
    • 世界のペットの狂犬病ワクチンの価格予測：用途別 (2026-2031)
  • 新たな成長源 ペットの狂犬病ワクチン アプリケーション

第5章 競合他社の状況

  • 世界のペットの狂犬病ワクチン 売上 ：競合別 (2020-2025)
  • 世界のペットの狂犬病ワクチンの上位企業：収益別 (2020-2025)
  • 世界のペットの狂犬病ワクチンの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3) & (収益ベース ペットの狂犬病ワクチン 2024年)
  • 世界のペットの狂犬病ワクチン 企業別平均価格 (2020-2025)
  • 世界の主要メーカー ペットの狂犬病ワクチン, 製造拠点 & 本社
  • 世界の主要メーカー ペットの狂犬病ワクチン, 製品の種類・用途
  • 世界の主要メーカー ペットの狂犬病ワクチン, 業界参入時期
  • 企業のM&A, 拡張計画

第6章 地域分析

  • 北米の市場: 参入企業、セグメント、下流、主要顧客
    • 北米のペットの狂犬病ワクチン 売上：企業別
    • 北米のペットの狂犬病ワクチン 売上 内訳 タイプ別 (2020-2025)
    • 北米のペットの狂犬病ワクチン 売上構成比：用途別 (2020-2025)
    • 北米のペットの狂犬病ワクチン 主要顧客
    • 北米の市場 トレンドと機会
  • 欧州の市場: 参入企業、セグメント、下流、主要顧客
    • 欧州のペットの狂犬病ワクチン 売上：企業別
    • 欧州のペットの狂犬病ワクチン 売上 内訳 タイプ別 (2020-2025)
    • 欧州のペットの狂犬病ワクチン 売上構成比：用途別 (2020-2025)
    • 欧州のペットの狂犬病ワクチン 主要顧客
    • 欧州の市場 トレンドと機会
  • 中国の市場: 参入企業、セグメント、下流、主要顧客
    • 中国のペットの狂犬病ワクチン 売上：企業別
    • 中国のペットの狂犬病ワクチン 売上 内訳 タイプ別 (2020-2025)
    • 中国のペットの狂犬病ワクチン 売上構成比：用途別 (2020-2025)
    • 中国のペットの狂犬病ワクチン 主要顧客
    • 中国の市場 トレンドと機会
  • 日本の市場: 参入企業、セグメント、下流、主要顧客
    • 日本のペットの狂犬病ワクチン 売上：企業別
    • 日本のペットの狂犬病ワクチン 売上 内訳 タイプ別 (2020-2025)
    • 日本のペットの狂犬病ワクチン 売上構成比：用途別 (2020-2025)
    • 日本のペットの狂犬病ワクチン 主要顧客
    • 日本の市場 トレンドと機会

第7章 企業概要と主要企業

  • Boehringer Ingelheim
  • Merck
  • Ceva Sante Animale
  • Everest Medicines
  • AKZO-NOBEL
  • Ringpu
  • China Resources Biomedical
  • Zoetis
  • Virbac
  • Bavarian Nordic
  • Dyntec
  • Sanofi-Pasteur

第8章 ペットの狂犬病ワクチン 製造コスト分析

  • ペットの狂犬病ワクチン 主要原材料の分析
    • 主要原材料
    • 原材料の主な調達先
  • 製造コスト構成比
  • 製造工程分析： ペットの狂犬病ワクチン
  • ペットの狂犬病ワクチン 産業チェーン分析

第9章 マーケティングチャネル, 販売店と顧客

  • マーケティングチャネル
  • ペットの狂犬病ワクチン 販売代理店一覧
  • ペットの狂犬病ワクチン 顧客

第10章 ペットの狂犬病ワクチン 市場動向

  • ペットの狂犬病ワクチン 業界動向
  • ペットの狂犬病ワクチン 市場の促進要因
  • ペットの狂犬病ワクチン 市場の課題
  • ペットの狂犬病ワクチン 市場の抑制要因

第11章 市場調査結果と結論

第12章 付録

図表

List of Tables

Table 1. Global Pets Rabies Vaccine Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Pets Rabies Vaccine Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Pets Rabies Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Pets Rabies Vaccine Sales (K Units) by Region (2020-2025)

Table 5. Global Pets Rabies Vaccine Sales Market Share by Region (2020-2025)

Table 6. Global Pets Rabies Vaccine Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Pets Rabies Vaccine Revenue Share by Region (2020-2025)

Table 8. Global Pets Rabies Vaccine Sales (K Units) Forecast by Region (2026-2031)

Table 9. Global Pets Rabies Vaccine Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Pets Rabies Vaccine Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Pets Rabies Vaccine Revenue Share Forecast by Region (2026-2031)

Table 12. Global Pets Rabies Vaccine Sales by Type (K Units) & (2020-2025)

Table 13. Global Pets Rabies Vaccine Sales Share by Type (2020-2025)

Table 14. Global Pets Rabies Vaccine Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Pets Rabies Vaccine Price by Type (US$/Unit) & (2020-2025)

Table 16. Global Pets Rabies Vaccine Sales by Type (K Units) & (2026-2031)

Table 17. Global Pets Rabies Vaccine Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Pets Rabies Vaccine Price by Type (US$/Unit) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Pets Rabies Vaccine Sales by Application (K Units) & (2020-2025)

Table 21. Global Pets Rabies Vaccine Sales Share by Application (2020-2025)

Table 22. Global Pets Rabies Vaccine Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Pets Rabies Vaccine Price by Application (US$/Unit) & (2020-2025)

Table 24. Global Pets Rabies Vaccine Sales by Application (K Units) & (2026-2031)

Table 25. Global Pets Rabies Vaccine Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Pets Rabies Vaccine Price by Application (US$/Unit) & (2026-2031)

Table 27. New Sources of Growth in Pets Rabies Vaccine Application

Table 28. Global Pets Rabies Vaccine Sales by Company (K Units) & (2020-2025)

Table 29. Global Pets Rabies Vaccine Sales Share by Company (2020-2025)

Table 30. Global Pets Rabies Vaccine Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Pets Rabies Vaccine Revenue Share by Company (2020-2025)

Table 32. Global Pets Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pets Rabies Vaccine as of 2024)

Table 33. Global Market Pets Rabies Vaccine Average Price by Company (US$/Unit) & (2020-2025)

Table 34. Global Key Manufacturers of Pets Rabies Vaccine, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Pets Rabies Vaccine, Product Type & Application

Table 36. Global Key Manufacturers of Pets Rabies Vaccine, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Pets Rabies Vaccine Sales by Company (2020-2025) & (K Units)

Table 39. North America Pets Rabies Vaccine Sales Market Share by Company (2020-2025)

Table 40. North America Pets Rabies Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Pets Rabies Vaccine Revenue Market Share by Company (2020-2025)

Table 42. North America Pets Rabies Vaccine Sales by Type (2020-2025) & (K Units)

Table 43. North America Pets Rabies Vaccine Sales Market Share by Type (2020-2025)

Table 44. North America Pets Rabies Vaccine Sales by Application (2020-2025) & (K Units)

Table 45. North America Pets Rabies Vaccine Sales Market Share by Application (2020-2025)

Table 46. Europe Pets Rabies Vaccine Sales by Company (2020-2025) & (K Units)

Table 47. Europe Pets Rabies Vaccine Sales Market Share by Company (2020-2025)

Table 48. Europe Pets Rabies Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Pets Rabies Vaccine Revenue Market Share by Company (2020-2025)

Table 50. Europe Pets Rabies Vaccine Sales by Type (2020-2025) & (K Units)

Table 51. Europe Pets Rabies Vaccine Sales Market Share by Type (2020-2025)

Table 52. Europe Pets Rabies Vaccine Sales by Application (2020-2025) & (K Units)

Table 53. Europe Pets Rabies Vaccine Sales Market Share by Application (2020-2025)

Table 54. China Pets Rabies Vaccine Sales by Company (2020-2025) & (K Units)

Table 55. China Pets Rabies Vaccine Sales Market Share by Company (2020-2025)

Table 56. China Pets Rabies Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Pets Rabies Vaccine Revenue Market Share by Company (2020-2025)

Table 58. China Pets Rabies Vaccine Sales by Type (2020-2025) & (K Units)

Table 59. China Pets Rabies Vaccine Sales Market Share by Type (2020-2025)

Table 60. China Pets Rabies Vaccine Sales by Application (2020-2025) & (K Units)

Table 61. China Pets Rabies Vaccine Sales Market Share by Application (2020-2025)

Table 62. Japan Pets Rabies Vaccine Sales by Company (2020-2025) & (K Units)

Table 63. Japan Pets Rabies Vaccine Sales Market Share by Company (2020-2025)

Table 64. Japan Pets Rabies Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Pets Rabies Vaccine Revenue Market Share by Company (2020-2025)

Table 66. Japan Pets Rabies Vaccine Sales by Type (2020-2025) & (K Units)

Table 67. Japan Pets Rabies Vaccine Sales Market Share by Type (2020-2025)

Table 68. Japan Pets Rabies Vaccine Sales by Application (2020-2025) & (K Units)

Table 69. Japan Pets Rabies Vaccine Sales Market Share by Application (2020-2025)

Table 70. Boehringer Ingelheim Company Information

Table 71. Boehringer Ingelheim Description and Business Overview

Table 72. Boehringer Ingelheim Pets Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Boehringer Ingelheim Pets Rabies Vaccine Product

Table 74. Boehringer Ingelheim Recent Development

Table 75. Merck Company Information

Table 76. Merck Description and Business Overview

Table 77. Merck Pets Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Merck Pets Rabies Vaccine Product

Table 79. Merck Recent Development

Table 80. Ceva Sante Animale Company Information

Table 81. Ceva Sante Animale Description and Business Overview

Table 82. Ceva Sante Animale Pets Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Ceva Sante Animale Pets Rabies Vaccine Product

Table 84. Ceva Sante Animale Recent Development

Table 85. Everest Medicines Company Information

Table 86. Everest Medicines Description and Business Overview

Table 87. Everest Medicines Pets Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Everest Medicines Pets Rabies Vaccine Product

Table 89. Everest Medicines Recent Development

Table 90. AKZO-NOBEL Company Information

Table 91. AKZO-NOBEL Description and Business Overview

Table 92. AKZO-NOBEL Pets Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. AKZO-NOBEL Pets Rabies Vaccine Product

Table 94. AKZO-NOBEL Recent Development

Table 95. Ringpu Company Information

Table 96. Ringpu Description and Business Overview

Table 97. Ringpu Pets Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Ringpu Pets Rabies Vaccine Product

Table 99. Ringpu Recent Development

Table 100. China Resources Biomedical Company Information

Table 101. China Resources Biomedical Description and Business Overview

Table 102. China Resources Biomedical Pets Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. China Resources Biomedical Pets Rabies Vaccine Product

Table 104. China Resources Biomedical Recent Development

Table 105. Zoetis Company Information

Table 106. Zoetis Description and Business Overview

Table 107. Zoetis Pets Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Zoetis Pets Rabies Vaccine Product

Table 109. Zoetis Recent Development

Table 110. Virbac Company Information

Table 111. Virbac Description and Business Overview

Table 112. Virbac Pets Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Virbac Pets Rabies Vaccine Product

Table 114. Virbac Recent Development

Table 115. Bavarian Nordic Company Information

Table 116. Bavarian Nordic Description and Business Overview

Table 117. Bavarian Nordic Pets Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Bavarian Nordic Pets Rabies Vaccine Product

Table 119. Bavarian Nordic Recent Development

Table 120. Dyntec Company Information

Table 121. Dyntec Description and Business Overview

Table 122. Dyntec Pets Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Dyntec Pets Rabies Vaccine Product

Table 124. Dyntec Recent Development

Table 125. Sanofi-Pasteur Company Information

Table 126. Sanofi-Pasteur Description and Business Overview

Table 127. Sanofi-Pasteur Pets Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Sanofi-Pasteur Pets Rabies Vaccine Product

Table 129. Sanofi-Pasteur Recent Development

Table 130. Production Base and Market Concentration Rate of Raw Material

Table 131. Key Suppliers of Raw Materials

Table 132. Pets Rabies Vaccine Distributors List

Table 133. Pets Rabies Vaccine Customers List

Table 134. Pets Rabies Vaccine Market Trends

Table 135. Pets Rabies Vaccine Market Drivers

Table 136. Pets Rabies Vaccine Market Challenges

Table 137. Pets Rabies Vaccine Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Pets Rabies Vaccine Product Picture

Figure 2. Global Pets Rabies Vaccine Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Pets Rabies Vaccine Sales Market Share by Type in 2024 & 2031

Figure 4. Animal Cell Culture Vaccines Product Picture

Figure 5. Human Cell Culture Vaccines Product Picture

Figure 6. Global Pets Rabies Vaccine Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 7. Global Pets Rabies Vaccine Sales Market Share by Application in 2024 & 2031

Figure 8. For Dogs Examples

Figure 9. For Cats Examples

Figure 10. For Other Pets Examples

Figure 11. Global Pets Rabies Vaccine Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Pets Rabies Vaccine Sales Growth Rate (2020-2031) & (US$ Million)

Figure 13. Global Pets Rabies Vaccine Sales (K Units) Growth Rate (2020-2031)

Figure 14. Global Pets Rabies Vaccine Price Trends Growth Rate (2020-2031) & (US$/Unit)

Figure 15. Pets Rabies Vaccine Report Years Considered

Figure 16. Global Market Pets Rabies Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 17. Global Pets Rabies Vaccine Revenue Market Share by Region: 2020 VS 2024

Figure 18. North America Pets Rabies Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. North America Pets Rabies Vaccine Sales (K Units) Growth Rate (2020-2031)

Figure 20. Europe Pets Rabies Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Europe Pets Rabies Vaccine Sales (K Units) Growth Rate (2020-2031)

Figure 22. China Pets Rabies Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. China Pets Rabies Vaccine Sales (K Units) Growth Rate (2020-2031)

Figure 24. Japan Pets Rabies Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 25. Japan Pets Rabies Vaccine Sales (K Units) Growth Rate (2020-2031)

Figure 26. Global Pets Rabies Vaccine Revenue Share by Type (2020-2025)

Figure 27. Global Pets Rabies Vaccine Sales Share by Type (2026-2031)

Figure 28. Global Pets Rabies Vaccine Revenue Share by Type (2026-2031)

Figure 29. Global Pets Rabies Vaccine Revenue Share by Application (2020-2025)

Figure 30. Global Pets Rabies Vaccine Revenue Growth Rate by Application in 2020 & 2024

Figure 31. Global Pets Rabies Vaccine Sales Share by Application (2026-2031)

Figure 32. Global Pets Rabies Vaccine Revenue Share by Application (2026-2031)

Figure 33. Global Pets Rabies Vaccine Sales Share by Company (2024)

Figure 34. Global Pets Rabies Vaccine Revenue Share by Company (2024)

Figure 35. Global 5 Largest Pets Rabies Vaccine Players Market Share by Revenue in Pets Rabies Vaccine: 2020 & 2024

Figure 36. Pets Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 37. Manufacturing Cost Structure of Pets Rabies Vaccine

Figure 38. Manufacturing Process Analysis of Pets Rabies Vaccine

Figure 39. Pets Rabies Vaccine Industrial Chain

Figure 40. Channels of Distribution (Direct Vs Distribution)

Figure 41. Distributors Profiles

Figure 42. Bottom-up and Top-down Approaches for This Report

Figure 43. Data Triangulation

Figure 44. Key Executives Interviewed

目次

This research report focuses on the Pets Rabies Vaccine Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Market Overview

  • 1.1 Pets Rabies Vaccine Product Scope
  • 1.2 Pets Rabies Vaccine by Type
    • 1.2.1 Global Pets Rabies Vaccine Sales by Type (2020 & 2024 & 2031)
    • 1.2.2 Animal Cell Culture Vaccines
    • 1.2.3 Human Cell Culture Vaccines
  • 1.3 Pets Rabies Vaccine by Application
    • 1.3.1 Global Pets Rabies Vaccine Sales Comparison by Application (2020 & 2024 & 2031)
    • 1.3.2 For Dogs
    • 1.3.3 For Cats
    • 1.3.4 For Other Pets
  • 1.4 Global Pets Rabies Vaccine Market Estimates and Forecasts (2020-2031)
    • 1.4.1 Global Pets Rabies Vaccine Market Size in Value Growth Rate (2020-2031)
    • 1.4.2 Global Pets Rabies Vaccine Market Size in Volume Growth Rate (2020-2031)
    • 1.4.3 Global Pets Rabies Vaccine Price Trends (2020-2031)
  • 1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

  • 2.1 Global Pets Rabies Vaccine Market Size by Region: 2020 VS 2024 VS 2031
  • 2.2 Global Pets Rabies Vaccine Retrospective Market Scenario by Region (2020-2025)
    • 2.2.1 Global Pets Rabies Vaccine Sales Market Share by Region (2020-2025)
    • 2.2.2 Global Pets Rabies Vaccine Revenue Market Share by Region (2020-2025)
  • 2.3 Global Pets Rabies Vaccine Market Estimates and Forecasts by Region (2026-2031)
    • 2.3.1 Global Pets Rabies Vaccine Sales Estimates and Forecasts by Region (2026-2031)
    • 2.3.2 Global Pets Rabies Vaccine Revenue Forecast by Region (2026-2031)
  • 2.4 Major Region and Emerging Market Analysis
    • 2.4.1 North America Pets Rabies Vaccine Market Size and Prospective (2020-2031)
    • 2.4.2 Europe Pets Rabies Vaccine Market Size and Prospective (2020-2031)
    • 2.4.3 China Pets Rabies Vaccine Market Size and Prospective (2020-2031)
    • 2.4.4 Japan Pets Rabies Vaccine Market Size and Prospective (2020-2031)

3 Global Market Size by Type

  • 3.1 Global Pets Rabies Vaccine Historic Market Review by Type (2020-2025)
    • 3.1.1 Global Pets Rabies Vaccine Sales by Type (2020-2025)
    • 3.1.2 Global Pets Rabies Vaccine Revenue by Type (2020-2025)
    • 3.1.3 Global Pets Rabies Vaccine Price by Type (2020-2025)
  • 3.2 Global Pets Rabies Vaccine Market Estimates and Forecasts by Type (2026-2031)
    • 3.2.1 Global Pets Rabies Vaccine Sales Forecast by Type (2026-2031)
    • 3.2.2 Global Pets Rabies Vaccine Revenue Forecast by Type (2026-2031)
    • 3.2.3 Global Pets Rabies Vaccine Price Forecast by Type (2026-2031)
  • 3.3 Different Types Pets Rabies Vaccine Representative Players

4 Global Market Size by Application

  • 4.1 Global Pets Rabies Vaccine Historic Market Review by Application (2020-2025)
    • 4.1.1 Global Pets Rabies Vaccine Sales by Application (2020-2025)
    • 4.1.2 Global Pets Rabies Vaccine Revenue by Application (2020-2025)
    • 4.1.3 Global Pets Rabies Vaccine Price by Application (2020-2025)
  • 4.2 Global Pets Rabies Vaccine Market Estimates and Forecasts by Application (2026-2031)
    • 4.2.1 Global Pets Rabies Vaccine Sales Forecast by Application (2026-2031)
    • 4.2.2 Global Pets Rabies Vaccine Revenue Forecast by Application (2026-2031)
    • 4.2.3 Global Pets Rabies Vaccine Price Forecast by Application (2026-2031)
  • 4.3 New Sources of Growth in Pets Rabies Vaccine Application

5 Competition Landscape by Players

  • 5.1 Global Pets Rabies Vaccine Sales by Players (2020-2025)
  • 5.2 Global Top Pets Rabies Vaccine Players by Revenue (2020-2025)
  • 5.3 Global Pets Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pets Rabies Vaccine as of 2024)
  • 5.4 Global Pets Rabies Vaccine Average Price by Company (2020-2025)
  • 5.5 Global Key Manufacturers of Pets Rabies Vaccine, Manufacturing Sites & Headquarters
  • 5.6 Global Key Manufacturers of Pets Rabies Vaccine, Product Type & Application
  • 5.7 Global Key Manufacturers of Pets Rabies Vaccine, Date of Enter into This Industry
  • 5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

  • 6.1 North America Market: Players, Segments, Downstream and Major Customers
    • 6.1.1 North America Pets Rabies Vaccine Sales by Company
      • 6.1.1.1 North America Pets Rabies Vaccine Sales by Company (2020-2025)
      • 6.1.1.2 North America Pets Rabies Vaccine Revenue by Company (2020-2025)
    • 6.1.2 North America Pets Rabies Vaccine Sales Breakdown by Type (2020-2025)
    • 6.1.3 North America Pets Rabies Vaccine Sales Breakdown by Application (2020-2025)
    • 6.1.4 North America Pets Rabies Vaccine Major Customer
    • 6.1.5 North America Market Trend and Opportunities
  • 6.2 Europe Market: Players, Segments, Downstream and Major Customers
    • 6.2.1 Europe Pets Rabies Vaccine Sales by Company
      • 6.2.1.1 Europe Pets Rabies Vaccine Sales by Company (2020-2025)
      • 6.2.1.2 Europe Pets Rabies Vaccine Revenue by Company (2020-2025)
    • 6.2.2 Europe Pets Rabies Vaccine Sales Breakdown by Type (2020-2025)
    • 6.2.3 Europe Pets Rabies Vaccine Sales Breakdown by Application (2020-2025)
    • 6.2.4 Europe Pets Rabies Vaccine Major Customer
    • 6.2.5 Europe Market Trend and Opportunities
  • 6.3 China Market: Players, Segments, Downstream and Major Customers
    • 6.3.1 China Pets Rabies Vaccine Sales by Company
      • 6.3.1.1 China Pets Rabies Vaccine Sales by Company (2020-2025)
      • 6.3.1.2 China Pets Rabies Vaccine Revenue by Company (2020-2025)
    • 6.3.2 China Pets Rabies Vaccine Sales Breakdown by Type (2020-2025)
    • 6.3.3 China Pets Rabies Vaccine Sales Breakdown by Application (2020-2025)
    • 6.3.4 China Pets Rabies Vaccine Major Customer
    • 6.3.5 China Market Trend and Opportunities
  • 6.4 Japan Market: Players, Segments, Downstream and Major Customers
    • 6.4.1 Japan Pets Rabies Vaccine Sales by Company
      • 6.4.1.1 Japan Pets Rabies Vaccine Sales by Company (2020-2025)
      • 6.4.1.2 Japan Pets Rabies Vaccine Revenue by Company (2020-2025)
    • 6.4.2 Japan Pets Rabies Vaccine Sales Breakdown by Type (2020-2025)
    • 6.4.3 Japan Pets Rabies Vaccine Sales Breakdown by Application (2020-2025)
    • 6.4.4 Japan Pets Rabies Vaccine Major Customer
    • 6.4.5 Japan Market Trend and Opportunities

7 Company Profiles and Key Figures

  • 7.1 Boehringer Ingelheim
    • 7.1.1 Boehringer Ingelheim Company Information
    • 7.1.2 Boehringer Ingelheim Business Overview
    • 7.1.3 Boehringer Ingelheim Pets Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.1.4 Boehringer Ingelheim Pets Rabies Vaccine Products Offered
    • 7.1.5 Boehringer Ingelheim Recent Development
  • 7.2 Merck
    • 7.2.1 Merck Company Information
    • 7.2.2 Merck Business Overview
    • 7.2.3 Merck Pets Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.2.4 Merck Pets Rabies Vaccine Products Offered
    • 7.2.5 Merck Recent Development
  • 7.3 Ceva Sante Animale
    • 7.3.1 Ceva Sante Animale Company Information
    • 7.3.2 Ceva Sante Animale Business Overview
    • 7.3.3 Ceva Sante Animale Pets Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.3.4 Ceva Sante Animale Pets Rabies Vaccine Products Offered
    • 7.3.5 Ceva Sante Animale Recent Development
  • 7.4 Everest Medicines
    • 7.4.1 Everest Medicines Company Information
    • 7.4.2 Everest Medicines Business Overview
    • 7.4.3 Everest Medicines Pets Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.4.4 Everest Medicines Pets Rabies Vaccine Products Offered
    • 7.4.5 Everest Medicines Recent Development
  • 7.5 AKZO-NOBEL
    • 7.5.1 AKZO-NOBEL Company Information
    • 7.5.2 AKZO-NOBEL Business Overview
    • 7.5.3 AKZO-NOBEL Pets Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.5.4 AKZO-NOBEL Pets Rabies Vaccine Products Offered
    • 7.5.5 AKZO-NOBEL Recent Development
  • 7.6 Ringpu
    • 7.6.1 Ringpu Company Information
    • 7.6.2 Ringpu Business Overview
    • 7.6.3 Ringpu Pets Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.6.4 Ringpu Pets Rabies Vaccine Products Offered
    • 7.6.5 Ringpu Recent Development
  • 7.7 China Resources Biomedical
    • 7.7.1 China Resources Biomedical Company Information
    • 7.7.2 China Resources Biomedical Business Overview
    • 7.7.3 China Resources Biomedical Pets Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.7.4 China Resources Biomedical Pets Rabies Vaccine Products Offered
    • 7.7.5 China Resources Biomedical Recent Development
  • 7.8 Zoetis
    • 7.8.1 Zoetis Company Information
    • 7.8.2 Zoetis Business Overview
    • 7.8.3 Zoetis Pets Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.8.4 Zoetis Pets Rabies Vaccine Products Offered
    • 7.8.5 Zoetis Recent Development
  • 7.9 Virbac
    • 7.9.1 Virbac Company Information
    • 7.9.2 Virbac Business Overview
    • 7.9.3 Virbac Pets Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.9.4 Virbac Pets Rabies Vaccine Products Offered
    • 7.9.5 Virbac Recent Development
  • 7.10 Bavarian Nordic
    • 7.10.1 Bavarian Nordic Company Information
    • 7.10.2 Bavarian Nordic Business Overview
    • 7.10.3 Bavarian Nordic Pets Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.10.4 Bavarian Nordic Pets Rabies Vaccine Products Offered
    • 7.10.5 Bavarian Nordic Recent Development
  • 7.11 Dyntec
    • 7.11.1 Dyntec Company Information
    • 7.11.2 Dyntec Business Overview
    • 7.11.3 Dyntec Pets Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.11.4 Dyntec Pets Rabies Vaccine Products Offered
    • 7.11.5 Dyntec Recent Development
  • 7.12 Sanofi-Pasteur
    • 7.12.1 Sanofi-Pasteur Company Information
    • 7.12.2 Sanofi-Pasteur Business Overview
    • 7.12.3 Sanofi-Pasteur Pets Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.12.4 Sanofi-Pasteur Pets Rabies Vaccine Products Offered
    • 7.12.5 Sanofi-Pasteur Recent Development

8 Pets Rabies Vaccine Manufacturing Cost Analysis

  • 8.1 Pets Rabies Vaccine Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Pets Rabies Vaccine
  • 8.4 Pets Rabies Vaccine Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Pets Rabies Vaccine Distributors List
  • 9.3 Pets Rabies Vaccine Customers

10 Pets Rabies Vaccine Market Dynamics

  • 10.1 Pets Rabies Vaccine Industry Trends
  • 10.2 Pets Rabies Vaccine Market Drivers
  • 10.3 Pets Rabies Vaccine Market Challenges
  • 10.4 Pets Rabies Vaccine Market Restraints

11 Research Findings and Conclusion

12 Appendix

  • 12.1 Research Methodology
    • 12.1.1 Methodology/Research Approach
      • 12.1.1.1 Research Programs/Design
      • 12.1.1.2 Market Size Estimation
      • 12.1.1.3 Market Breakdown and Data Triangulation
    • 12.1.2 Data Source
      • 12.1.2.1 Secondary Sources
      • 12.1.2.2 Primary Sources
  • 12.2 Author Details
  • 12.3 Disclaimer